727 related articles for article (PubMed ID: 6161325)
1. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
Scagliusi P; Muratore M; Martiradonna A; Berlingerio G; Carrozzo M
Minerva Med; 1980 Dec; 71(50):3655-63. PubMed ID: 6161325
[TBL] [Abstract][Full Text] [Related]
2. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
3. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to native DNA in connective tissue disease. A comparison of radioimmunoassay, counterimmunoelectrophoresis and indirect immunofluorescence on Crithidia luciliae substrate.
Hodinka L; Merétey K; Jancsó A; Falus A; Korda J; Bozsóky S
Arch Immunol Ther Exp (Warsz); 1979; 27(5):641-6. PubMed ID: 398205
[TBL] [Abstract][Full Text] [Related]
5. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
[TBL] [Abstract][Full Text] [Related]
6. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
Bodolay E; Szegedi G
Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
[TBL] [Abstract][Full Text] [Related]
7. Antibody to extractable nuclear antigen in the rheumatic diseases.
McCain GA; Bell DA; Chodirker WB; Komar RR
J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
Yamagata H; Akizuki M; Tojo T; Homma M
Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
[TBL] [Abstract][Full Text] [Related]
9. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
[TBL] [Abstract][Full Text] [Related]
10. [Significance of anticardiolipin antibodies in connective tissue diseases].
Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
[TBL] [Abstract][Full Text] [Related]
11. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
12. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
13. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
Molden DP; Suzuki H; Nakamura RM
Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
Farber SJ; Bole GG
Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
Cortés JJ; Mendoza F; Reyes PA
J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
[TBL] [Abstract][Full Text] [Related]
18. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.
Alarcón-Segovia D; Cardiel MH
J Rheumatol; 1989 Mar; 16(3):328-34. PubMed ID: 2724251
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
